Figure 3 shows that CALR siRNA almost completely abolishes FNMA in Dex-induced GBM cells when assessed by both immunoblot (Figure 4A) and immunofluorescence (Figure 4B) analysis. The gene discussed is CALR; the disease is glioblastoma.